Clinical Report: Compartmentalized Lung Subphenotypes in Pneumonia

Overview

Transcriptomic analysis of bronchoalveolar lavage (BAL) cells in severe pneumonia identified three pulmonary subphenotypes, termed pneumotypes, that were not detectable in blood. Pneumotypes differed in inflammatory profile and clinical outcomes, and their interaction with blood subphenotypes was associated with mortality. The supplied article excerpt describes Pn1 and Pn2; it does not provide the detailed characteristics of Pn3.

Background

Pneumonia is described as both the most frequent individual infection prompting ICU admission and the leading nosocomial infection arising during an ICU stay. Its clinical and radiological manifestations are heterogeneous, although the presumed histological substrate is generally neutrophil-predominant consolidation, sometimes with diffuse alveolar damage and hyaline membranes. Reproducible blood phenotypes in ARDS and respiratory sepsis have renewed interest in stratified treatment, but blood may not represent pulmonary inflammation. The article therefore examines pulmonary subphenotypes identified through BAL-cell transcriptomics in severe pneumonia.

Data Highlights

Key Findings

• BAL-cell transcriptomic analysis identified three pulmonary phenotypes—Pn1, Pn2, and Pn3—described as immunologically silent, balanced, and hyperinflammatory with immature neutrophils, respectively.
• The pneumotypes were not detectable in blood; blood analysis instead identified two subphenotypes related to Sepsis Response Signatures.
• Pneumotype and blood type interacted in predicting mortality. The poorest outcomes were reported in patients with the least pulmonary inflammation and the more inflammatory blood signature.
• Pn1 was characterized by low alveolar cytokines, sparse neutrophils, expanded alveolar macrophages, severe respiratory failure, and frequent alveolar haemorrhage. Although Pn1 was more frequent in immunosuppressed patients, 44% of affected individuals were not immunosuppressed.
• The authors propose abnormal surfactant processing and epithelial injury as possible mechanisms in Pn1, while noting that these mechanisms remain unconfirmed and require further investigation.
• Pn2 had an intermediate immune profile, strong epithelial-repair and stem-cell signatures, and the most favorable outcomes; patients classified as Pn2 achieved ventilator liberation sooner than those in the other phenotypes.

Clinical Implications

The findings indicate that peripheral blood phenotyping alone may not capture pulmonary inflammatory states in severe pneumonia, and the authors report that lung and blood phenotypes jointly related to mortality. The proposed Pn1 mechanisms are explicitly unconfirmed, and the supplied excerpt does not establish phenotype-directed treatments or provide the full results for Pn3.

Conclusion

The reported BAL analysis identifies distinct pulmonary inflammatory patterns in severe pneumonia, including a low-inflammatory lung phenotype associated with severe injury and a balanced phenotype associated with more favorable outcomes. Further investigation is needed to confirm proposed mechanisms and establish the clinical role of pneumotype classification.

Related Resources & Content

1. Nature Communications, 2026 -- Pulmonary inflammation in severe pneumonia is characterised by compartmentalised and mechanistically distinct sub-phenotypes
2. Intensive Care Medicine -- Subphenotypes of Sepsis, Theragnostic Approaches, and Tailored Management Strategies
3. Critical Care (Springer) -- Subphenotypes of mechanically ventilated acute respiratory distress syndrome patients based on multi-dimensional pathophysiological parameters
4. Intensive Care Medicine — Exploring Tailored Respiratory Interventions for Various Phenotypes of COVID-19 Pneumonia
5. Frontiers in Immunology — Assessment of Immune Responses, Phenotypic Characterization, and Targeted Therapies in Severe Pneumonia: Existing Evidence and Implementation Challenges
6. Pulmonary inflammation in severe pneumonia is characterised by compartmentalised and mechanistically distinct sub-phenotypes
7. Subphenotypes of Sepsis, Theragnostic Approaches, and Tailored Management Strategies
8. Subphenotypes of mechanically ventilated acute respiratory distress syndrome patients based on multi-dimensional pathophysiological parameters
9. Diagnosis and Management of Community-acquired Pneumonia: An Official American Thoracic Society Clinical Practice Guideline | American Journal of Respiratory and Critical Care Medicine | Oxford Academic
10. Hydrocortisone in Severe Community-Acquired Pneumonia | New England Journal of Medicine
11. Pulmonary inflammation in severe pneumonia is characterised by compartmentalised and mechanistically distinct sub-phenotypes | Nature Communications